Reduce time to launch with Tempus and multimodal data

How AstraZeneca simplified its approach to TROPION-Lung01 and drove down time to launch.

Read more

Make quicker decisions by simulating and contextualizing data with Tempus

Mirati leverages Tempus data to revise its KRAS strategy and refine its patient selection approach

Read more

Enhance your clinical development process with Tempus’ CDx platform

Learn how A2 Biotherapeutics is making progress on a breakthrough cell therapy using HLA-LOH (human leukocyte antigen-loss of heterozygosity) as a biomarker, using Tempus’ comprehensive immunotherapy platform.

Read more